Avanos Medical, Inc.

NYSE:AVNS 株式レポート

時価総額:US$1.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Avanos Medical 配当金

配当金 基準チェック /06

Avanos Medical配当金を支払った記録がありません。

主要情報

n/a

配当利回り

n/a

配当性向

業界平均利回り1.7%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金n/a
一株当たり利益US$0.16
配当利回り予想n/a

最近の配当金アップデート

更新なし

Recent updates

There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings

Aug 07
There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings

Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S

Apr 17
Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S

Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Jan 05
Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

Aug 14
Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Aug 13
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy

Jul 16

We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Jun 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

May 18
Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

May 07
Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Mar 02
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Avanos Medical Q4 2022 Earnings Preview

Feb 20

Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Feb 10
Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Jan 13
Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance

Nov 02

Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate

Sep 12

Avanos Medical Q2 2022 Earnings Preview

Aug 08

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

May 28
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

May 03
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Feb 10
Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

Dec 21
Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

Nov 04
An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt

Sep 10
Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt

The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business

Aug 10
The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business

Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?

Jun 30
Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?

We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt

Jun 09
We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt

決済の安定と成長

配当データの取得

安定した配当: AVNSの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。

増加する配当: AVNSの配当金が増加しているかどうかを判断するにはデータが不十分です。


配当利回り対市場

Avanos Medical 配当利回り対市場
AVNS 配当利回りは市場と比べてどうか?
セグメント配当利回り
会社 (AVNS)n/a
市場下位25% (US)1.4%
市場トップ25% (US)4.3%
業界平均 (Medical Equipment)1.7%
アナリスト予想 (AVNS) (最長3年)n/a

注目すべき配当: AVNSは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。

高配当: AVNSは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。


株主への利益配当

収益カバレッジ: AVNSの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。


株主配当金

キャッシュフローカバレッジ: AVNSが配当金を報告していないため、配当金の持続可能性を計算できません。


高配当企業の発掘